Oversight of Clinical Investigations: A RiskBased Approach to Monitoring (Draft Guidance) U.S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluatio

First Page		Document Content
Pharmaceutical industry Pharmacology Food and Drug Administration Clinical trial Clinical investigator Regulatory requirement Good Clinical Practice Center for Drug Evaluation and Research Good Clinical Data Management Practice Clinical research Research Pharmaceutical sciences		Oversight of Clinical Investigations: A RiskBased Approach to Monitoring (Draft Guidance) U.S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluatio Add to Reading List Source URL: www.fda.gov. Download Document from Source Website File Size: 525,67 KB Share Document on Facebook

	Workshop: How to be a good Chief Investigator 18 October 2016 Bristol A free one day training event for newly funded Chief Investigators on randomised clinical trials. The workshop will include panel discussions, present DocID: 1rXgp - View Document
	2016 Call for Proposals: ACVIM Foundation / Zoetis Partnership Research grant with direct clinical application Background: The ACVIM Foundation (ACVIMF) and Zoetis have partnered to grant up to $60,000 for a project that DocID: 1rthB - View Document
	Food and Drug Administration, HHS § 50.3 PART 50—PROTECTION OF HUMAN SUBJECTS DocID: 1rraL - View Document
	Identifying Investigators DocID: 1rqU5 - View Document
	Can Cancer Experts Accurately Forecast the Replication of Cancer Biology Experiments? Lead Investigator: Jonathan Kimmelman Co-investigators: Daniel Benjamin Funding Agency: Canadian Institutes of Health Research Term: F DocID: 1rp2G - View Document